Management of severe heart failure

Circulation Journal

Volumn 73, Issue SUPPL. A, 2009, Pages

  Hiramitsu, Shinya ^a   Miyagishima, Kenji ^b   Kimura, Hisashi ^b   Mori, Kazumasa ^b   Shiino, Kenji ^b   Yamada, Akira ^b   Kato, Shigeru ^b   Kato, Yasuchika ^b   Morimoto, Shin Ichiro ^b   Hishida, Hitoshi ^b   Ozaki, Yukio ^b  

^a Hiramitsu Clinic   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute heart failure; Chronic heart failure; Dilated cardiomyopathy; End stage heart failure; Heart transplantation

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR ALPHA; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ENALAPRIL; EPLERENONE; FUROSEMIDE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; INOTROPIC AGENT; ISOSORBIDE DINITRATE; LISINOPRIL; MILRINONE; NITRATE; ORPLINONE; PIMOBENDAN; PLACEBO; SPIRONOLACTONE; UNCLASSIFIED DRUG; VALSARTAN;

ACUTE HEART INFARCTION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CONVALESCENCE; DISEASE EXACERBATION; DIZZINESS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG WITHDRAWAL; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART SURGERY; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOTENSION; JAPAN; LOW DRUG DOSE; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIURETICS; DRUG THERAPY, COMBINATION; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 67650572121     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1106     Document Type: Review

References (31)

1. Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, et al. Navigating the crossroad of coronary artery disease and heart failure. Circulation 2006; 114: 1202-1213. (Pubitemid 44386485)
2. Gheorghiade M, Filippatos G, Luca LD, Burnett J. Congestion in acute heart failure syndromes: An essential target of evaluation and treatment. Am J Med 2006; 119: S3-S10. (Pubitemid 44755377)
3. Miyagishima K, Hiramitsu S, Kimura H, Mori K, Ueda T, Kato S, et al. Long term prognosis of chronic heart failure with preserved vs reduced left ventricular ejection fraction. Circ J 2009; 73: 92-99.
4. Okura Y, Ohno Y, Ramadan MM, Suzuki K, Taneda K, Obata H, et al. Characterization of outpatients with isolated diastolic dysfunction and evaluation of the burden in a Japanese community: Sado Heart Failure Study. Circ J 2007; 71: 1013-1021.
5. Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001; 88: 530-533. (Pubitemid 32778500)
6. Japanese beta-Blockers and Calcium Antagonists Myocardial Infarction (JBCMI) Investigators. Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiol 2004; 15: 969-973.
7. Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2006). htto://www.j-circ.or.jp/giudeline/pdf/JCS2006-ishikawa-h.pdf (accessed on April 1, 2009).
8. Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function. Circulation 1987; 76: 115-124. (Pubitemid 17093199)
9. Hata N, Seino Y, Tsutamoto T, Hiramitsu S, Kaneko N, Yoshikawa T, et al. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure. Circ J 2008; 72: 1787-1793.
10. Nomura F, Kurobe N, Mori Y, Hikita A, Kawai M, Suwa M, et al. Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure. COMPASS: Carperitide effects observed through monitoring dyspnea in acute decompensated heart failure study. Circ J 2008; 72: 1777-1786.
11. Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND). Lancet 2007; 370: 1483-1493. (Pubitemid 47625560)
12. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, et al. Effect of oral milrinone on mortality in severe chronic heart failure: The PROMISE Study Research Group. N Engl J Med 1991; 21: 1468-1475.
13. Hampton JR, van Veldhuisen DJ, Kleber FX, Cowley AJ, Ardia A, Block P, et al. Randomized study of effect of ibopamine on survival in patients with advanced severe heart failure: Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators. Lancet 1997; 349: 971-977.
14. Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure: Vesnarinone Trial Investigators. N Engl J Med 1998; 339: 1810-1816.
15. Shinagawa H, Inomata T, Koitabashi T, Nakano H, Takeuchi I, Naruke T, et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J 2008; 72: 364-369. (Pubitemid 351600627)
16. Okura H, Kubo T, Asawa K, Toda I, Yoshiyama M, Yoshikawa J, et al. Elevated E/E' predicts prognosis in congestive heart failure patients with preserved systolic function. Circ J 2009; 73: 86-91.
17. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology: Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
18. Yoshikawa T, Baba A, Suzuki M, Yokozuka H, Okada Y, Nagami K, et al. Effectiveness of carvedilol alone versus carvedilol+pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group. Am J Cardiol 2000; 15: 1495-1497.
19. Krum H, Shusterman N, MacMahon S, Sharpe N, for the Australia/New Zealand heart failure research collaborative group. Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. J Card Fail 1998; 4: 281-288.
20. Silverberg DS, Wexler D, Blum M, Iaina A. The cardio renal anemia syndrome: Correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin Nephrol 2003; 60: S93-S102. (Pubitemid 36889544)
21. Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit Care Med 2004; 32: 1310-1315. (Pubitemid 38738585)
22. Okondo DO, Grzesio A, Witkowski T, Mandal AK, Slater RM, Roughton M, et al. Effects of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: A randomized, controlled, observer- blinded trial. J Am Coll Cardiol 2008; 51: 103-112.
23. Van Veldhuisen DJ, Dickstein K, Cohen-Sotal A, Lok DJ, Wasserman SM, Baker N, et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anemia. Eur Heart J 2007; 28: 2208-2216. (Pubitemid 47428946)
24. Ghali JK, Anand IS, Abraham WT, Fonarow GC, Greenberg B, Krum H, et al; Study of Anemia in Heart Failure Trial (STAMINA-HeFT) Group. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 2008; 117: 526-535.
25. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008; 117: 2608-2616.
26. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150. (Pubitemid 38637994)
27. Rivero-Ayerza M, Theuns DA, Garcia HM, Boersma E, Simoons M, Jordaens LJ. Effects of cardiac resynchronization therapy on overall mortality and mode of death: A meta-analysis of randomized controlled trials. Eur Heart J 2006; 27: 2682-2688. (Pubitemid 44729869)
28. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2005; 112: 154-235.
29. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998; 115: 381-386. (Pubitemid 28093753)
30. Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, et al. The REMATCH trial: Rationale, design, and end points: Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg 1999; 67: 723-730.
31. Birks EJ, Tansley PD, Hardy J, George R, Bowles CT, Burke M, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006; 355: 1873-1883. (Pubitemid 44664645)